Oh J, Lee S, Park Y
BMC Cancer. 2025; 25(1):379.
PMID: 40022020
PMC: 11871754.
DOI: 10.1186/s12885-025-13727-7.
Ttofi E, Kyriacou C, Leontiou T, Parpottas Y
Life (Basel). 2025; 15(2).
PMID: 40003609
PMC: 11856228.
DOI: 10.3390/life15020200.
Yu Y, Li G, Tan W, Qu X, Zhang T, Hou X
BMC Med Imaging. 2025; 25(1):63.
PMID: 40000987
PMC: 11863488.
DOI: 10.1186/s12880-025-01596-2.
Yavuz G, Kovan B, Toklu T, Cermik T, Ozturk C
Biomed Eng Online. 2025; 24(1):20.
PMID: 39955528
PMC: 11830175.
DOI: 10.1186/s12938-025-01330-7.
Taralli S, Orlandi A, Pafundi P, Tempesta V, Di Leone A, Pontolillo L
Radiol Med. 2025; 130(3):422-437.
PMID: 39937369
DOI: 10.1007/s11547-025-01961-9.
Investigating the Impact of Voxel Size and Postfiltering on Quantitative Analysis of Positron Emission Tomography/Computed Tomography: A Phantom Study.
Mohymen A, Farag H, Reda S, Monem A, Ali S
J Med Phys. 2025; 49(4):597-607.
PMID: 39926131
PMC: 11801078.
DOI: 10.4103/jmp.jmp_123_24.
F-FDG PET/CT assessment of metabolic tumor burden predicts survival in patients with metastatic posterior uveal melanoma.
Hindso T, Martinussen T, Bjerrum C, Keller S, Loft A, Sjol M
Sci Rep. 2025; 15(1):4110.
PMID: 39901052
PMC: 11790917.
DOI: 10.1038/s41598-025-88625-w.
MIRD Pamphlet No. 32: A MIRD Recovery Coefficient Model for Resolution Characterization and Shape-Specific Partial-Volume Correction.
Marquis H, Schmidtlein C, de Nijs R, Minguez Gabina P, Gustafsson J, Kayal G
J Nucl Med. 2025; 66(3):457-465.
PMID: 39884774
PMC: 11876732.
DOI: 10.2967/jnumed.124.268520.
Translation of PET radiotracers for cancer imaging: recommendations from the National Cancer Imaging Translational Accelerator (NCITA) consensus meeting.
McAteer M, McGowan D, Cook G, Leung H, Ng T, OConnor J
BMC Med. 2025; 23(1):37.
PMID: 39849494
PMC: 11756105.
DOI: 10.1186/s12916-024-03831-z.
CD45-PET is a robust, non-invasive tool for imaging inflammation.
Salehi Farid A, Rowley J, Allen H, Kruger I, Tavakolpour S, Neeley K
Nature. 2025; 639(8053):214-224.
PMID: 39843738
DOI: 10.1038/s41586-024-08441-6.
Can PSMA PET detect intratumour heterogeneity in histological PSMA expression of primary prostate cancer? Analysis of [Ga]Ga-PSMA-11 and [F]PSMA-1007.
Waibel P, Glavynskyi I, Fechter T, Mix M, Kind F, Sigle A
Eur J Nucl Med Mol Imaging. 2025; .
PMID: 39821663
DOI: 10.1007/s00259-025-07078-5.
Device-assisted strategies for drug delivery across the blood-brain barrier to treat glioblastoma.
Mokarram N, Case A, Hossainy N, Lyon J, MacDonald T, Bellamkonda R
Commun Mater. 2025; 6(1):5.
PMID: 39790893
PMC: 11706785.
DOI: 10.1038/s43246-024-00721-y.
Inter- and intra-tumoral heterogeneity on [Ga]Ga-DOTA-TATE/[Ga]Ga-DOTA-TOC PET/CT predicts response to [Lu]Lu-DOTA-TATE PRRT in neuroendocrine tumor patients.
Gadens Zamboni C, Dundar A, Jain S, Kruzer M, Loeffler B, Graves S
EJNMMI Rep. 2024; 8(1):39.
PMID: 39613925
PMC: 11607192.
DOI: 10.1186/s41824-024-00227-3.
Partial volume correction for Lu-177-PSMA SPECT.
Liu Y, Lu Z, Chen G, Shi K, Mok G
EJNMMI Phys. 2024; 11(1):93.
PMID: 39528900
PMC: 11555037.
DOI: 10.1186/s40658-024-00697-1.
Using spatial frequency domain imaging to monitor a skin biopsy wound: a pilot study.
Zhang L, Bounds A, Girkin J
Biomed Opt Express. 2024; 15(10):5872-5885.
PMID: 39421765
PMC: 11482166.
DOI: 10.1364/BOE.536843.
Probabilistic deconvolution of PET images using informed priors.
Hansen T, Mosegaard K, Holm S, Andersen F, Fischer B, Hansen A
Front Nucl Med. 2024; 2:1028928.
PMID: 39381407
PMC: 11459987.
DOI: 10.3389/fnume.2022.1028928.
Advances and challenges in immunoPET methodology.
Mohr P, van Sluis J, Lub-de Hooge M, Lammertsma A, Brouwers A, Tsoumpas C
Front Nucl Med. 2024; 4:1360710.
PMID: 39355220
PMC: 11440922.
DOI: 10.3389/fnume.2024.1360710.
High Physiological F-FDG Uptake in Normal Pituitary Gland on Digital PET Scanner.
Jain A, Usmani S, Al Riyami K, Mittal A, Abubakar S, Al Busaidi A
World J Nucl Med. 2024; 23(3):161-167.
PMID: 39170838
PMC: 11335388.
DOI: 10.1055/s-0044-1786733.
Investigating the In Vivo Biodistribution of Extracellular Vesicles Isolated from Various Human Cell Sources Using Positron Emission Tomography.
Rosenkrans Z, Thickens A, Kink J, Aluicio-Sarduy E, Engle J, Hematti P
Mol Pharm. 2024; 21(9):4324-4335.
PMID: 39164886
PMC: 11891749.
DOI: 10.1021/acs.molpharmaceut.4c00298.
FDG uptake of pulmonary lesions in synchronous primary lung cancers and lung metastases.
Karpinski S, Al Bimani Z, Dobson J, Zeng W
Res Diagn Interv Imaging. 2024; 9:100041.
PMID: 39076580
PMC: 11265416.
DOI: 10.1016/j.redii.2024.100041.